BACKGROUND: During the first line defense of an infected host, circulating neutrophils invade the inflamed tissue, whereas mature neutrophils from the bone marrow pool migrate into the blood circulation and from there reinforce tissue infiltration. The CXC chemokine CXCL8, also know as interleukin-8, is a potent attractant of neutrophils. Recently, we discovered a new natural post-translational modification of CXCL8, i.e. the deimination of arginine into citrulline by peptidylarginine deiminases. DESIGN AND METHODS: The ability to provoke leukocytosis was assessed by intravenous administration of citrullinated CXCL8 in rabbits. Adsorption of citrullinated CXCL8 to the Duffy antigen/receptor for chemokines on human or rabbit erythrocytes was evaluated using a competitive binding assay. Finally, surface expression of adhesion molecules was studied after stimulating neutrophils with citrullinated CXCL8. RESULTS: Citrullination of CXCL8 significantly increased this chemokine's ability to recruit neutrophils into the blood circulation. In addition, the competitive binding properties of CXCL8 for the Duffy antigen/receptor for chemokines were impaired upon citrullination. Since the Duffy antigen/receptor for chemokines is an important scavenging receptor for CXCL8 in the blood stream, citrullination may delay CXCL8 clearance from the circulation. Furthermore, the shedding of CD62L (L-selectin) and the upregulation of CD11b (beta2-integrin) protein expression on CXCL8-induced neutrophils were improved by deimination of CXCL8, possibly contributing to the neutrophil egress from the bone marrow. Conversely, surface expression of CD15, the neutrophilic ligand of endothelial selectins, was equally well upregulated by intact and citrullinated CXCL8. CONCLUSIONS: These data show that citrullination of CXCL8 enhances leukocytosis, possibly through impaired chemokine clearance from the blood circulation and prolonged presentation to the bone marrow.
BACKGROUND: During the first line defense of an infected host, circulating neutrophils invade the inflamed tissue, whereas mature neutrophils from the bone marrow pool migrate into the blood circulation and from there reinforce tissue infiltration. The CXC chemokine CXCL8, also know as interleukin-8, is a potent attractant of neutrophils. Recently, we discovered a new natural post-translational modification of CXCL8, i.e. the deimination of arginine into citrulline by peptidylarginine deiminases. DESIGN AND METHODS: The ability to provoke leukocytosis was assessed by intravenous administration of citrullinated CXCL8 in rabbits. Adsorption of citrullinated CXCL8 to the Duffy antigen/receptor for chemokines on human or rabbit erythrocytes was evaluated using a competitive binding assay. Finally, surface expression of adhesion molecules was studied after stimulating neutrophils with citrullinated CXCL8. RESULTS: Citrullination of CXCL8 significantly increased this chemokine's ability to recruit neutrophils into the blood circulation. In addition, the competitive binding properties of CXCL8 for the Duffy antigen/receptor for chemokines were impaired upon citrullination. Since the Duffy antigen/receptor for chemokines is an important scavenging receptor for CXCL8 in the blood stream, citrullination may delay CXCL8 clearance from the circulation. Furthermore, the shedding of CD62L (L-selectin) and the upregulation of CD11b (beta2-integrin) protein expression on CXCL8-induced neutrophils were improved by deimination of CXCL8, possibly contributing to the neutrophil egress from the bone marrow. Conversely, surface expression of CD15, the neutrophilic ligand of endothelial selectins, was equally well upregulated by intact and citrullinated CXCL8. CONCLUSIONS: These data show that citrullination of CXCL8 enhances leukocytosis, possibly through impaired chemokine clearance from the blood circulation and prolonged presentation to the bone marrow.
Authors: P M Murphy; M Baggiolini; I F Charo; C A Hébert; R Horuk; K Matsushima; L H Miller; J J Oppenheim; C A Power Journal: Pharmacol Rev Date: 2000-03 Impact factor: 25.468
Authors: A Wuyts; E Schutyser; P Menten; S Struyf; A D'Haese; H Bult; G Opdenakker; P Proost; J Van Damme Journal: Biochemistry Date: 2000-11-28 Impact factor: 3.162
Authors: Monika Pruenster; Liesbeth Mudde; Paula Bombosi; Svetla Dimitrova; Marion Zsak; Jim Middleton; Ann Richmond; Gerard J Graham; Stephan Segerer; Robert J B Nibbs; Antal Rot Journal: Nat Immunol Date: 2008-12-07 Impact factor: 25.606
Authors: Eva A V Moelants; Gitte Loozen; Anneleen Mortier; Erik Martens; Ghislain Opdenakker; Danuta Mizgalska; Borys Szmigielski; Jan Potempa; Jo Van Damme; Wim Teughels; Paul Proost Journal: Infect Immun Date: 2014-03-31 Impact factor: 3.441
Authors: G-H Rong; G-X Yang; Y Ando; W Zhang; X-S He; P S C Leung; R L Coppel; A A Ansari; R Zhong; M E Gershwin Journal: Clin Exp Immunol Date: 2013-04 Impact factor: 4.330
Authors: K Gawron; G Bereta; Z Nowakowska; K Lazarz-Bartyzel; M Lazarz; B Szmigielski; D Mizgalska; A Buda; J Koziel; Z Oruba; M Chomyszyn-Gajewska; J Potempa Journal: Mol Oral Microbiol Date: 2014-10-21 Impact factor: 3.563
Authors: Anneleen Mortier; Nele Berghmans; Isabelle Ronsse; Karolien Grauwen; Steve Stegen; Jo Van Damme; Paul Proost Journal: PLoS One Date: 2011-08-31 Impact factor: 3.240